Vaxcyte

PCVX

1 Followers

$31.41

+8.31%

$2.41

14 May

Upcoming Earnings

Market Cap.

P/E

Overview Metrics Financials

PCVX Fair Price

$62.14

Undervalued by 81.9%

To display the fair price of a share, you need to be a member of Bulios Black.

My Notes

Začít psát

Profile

Vaxcyte is an American biotechnology company focused on developing vaccines for the prevention of serious infectious diseases. The company specializes in advanced vaccine technologies, including cellular therapies and protein-based vaccines, with the aim of providing effective protection against pathogens that currently lack sufficient vaccines. Vaxcyte is developing vaccines for infections such as pneumococcal disease and is working to improve immunization and the prevention of infectious diseases globally.

Feed

There are no posts to show right now.